SciTech and the Plough Center Announce Manufacturing Agreement

SciTech and the Plough Center Announce Manufacturing AgreementThe Contract Manufacturing Agreement Will Provide the Clinical Supply of ST-001, SciTech’s Lead Drug Candidate for Cancer NEWS PROVIDED BY SciTech Development, LLC October 20, 2022 GROSSE POINTE FARMS, Mich., October 20, 2022 (Newswire.com) – SciTech Development is pleased to announce that it has signed a $600K manufacturing…

SciTech Development, LLC Announces FDA Acceptance of Investigational New Drug (IND) Application for ST-001 nanoFenretinide in Patients with T-Cell Lymphoma

SciTech Development, LLC Announces FDA Acceptance of Investigational New Drug (IND) Application for ST-001 nanoFenretinide in Patients with T-Cell LymphomaCompany will present at Biotech Showcase™ 2020 on Monday, 01/13/20 at 11:15am PST in San Francisco, CA NEWS PROVIDED BY SciTech Development, LLC 23 Dec, 2019, 09:05 ET GROSSE POINTE FARMS, Mich., Dec. 23, 2019 /PRNewswire/…